Attention deficit-hyperactivity disorder. Disturbance of activity and attention
Conditions
Interventions
Intervention 1: Intervention group will receive 70 mg/kg/day of Piracetam syrup (product of Daroo pakhsh company which contains 33.3 g/dl of drug) every morning , half an hour after taking Methylpheni
Treatment - Drugs
Placebo
Intervention group will receive 70 mg/kg/day of Piracetam syrup (product of Daroo pakhsh company which contains 33.3 g/dl of drug) every morning , half an hour after taking Methylphenidate tablet.
Control group will receive 70 mg/kg/day of placebo ( Sucrose solution in the same package and same dilution as Piracetam syrup) half an hour after taking their Methylphenidate tablet.
Sponsors
Vice chancellor for Research Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
6 Years to 16 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria:Age 6-16; Diagnosis of ADHD for the first time Exclusion criteria : IQ<70 ; Having other chronic medical illnesses; Be under other medications; Any serious or sever complication during study; Refusal of child or parent to continue the study
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Attention, Impulsivity & Behavioral indecies. Timepoint: At the begining,3 weeks later & 6 weeks later. Method of measurement: Conner's parents questionaire.;Child's general function. Timepoint: At the begining of study , 3 weeks later , 6 weeks later. Method of measurement: CGAS questionare. | — |
Secondary
| Measure | Time frame |
|---|---|
| Drug complication. Timepoint: 3 weeks after begining of the study & 6 weeks later. Method of measurement: Rachell & klein Side effects Form. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Maryam Akbari
Tehran Institute of Psychiatry
Outcome results
None listed